The drugs give through oral.
This report contains market size and forecasts of Oral Peptide Therapy in global, including the following market information:
Global Oral Peptide Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oral Peptide Therapy Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Oral Peptide Therapy companies in 2021 (%)
The global Oral Peptide Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Linaclotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Peptide Therapy include Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis and Chiasma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Peptide Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Peptide Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Oral Peptide Therapy Market Segment Percentages, by Type, 2021 (%)
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Global Oral Peptide Therapy Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Oral Peptide Therapy Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Global Oral Peptide Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Oral Peptide Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Peptide Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oral Peptide Therapy revenues share in global market, 2021 (%)
Key companies Oral Peptide Therapy sales in global market, 2017-2022 (Estimated), (Units)
Key companies Oral Peptide Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma